TY - JOUR T1 - Surgical Resection of Malignancies Invading Inferior <em>Vena Cava</em> Level I and II. Issues Still Need to Be Discussed JF - Anticancer Research JO - Anticancer Res SP - 2523 LP - 2528 VL - 37 IS - 5 AU - EMILIO VICENTE AU - YOLANDA QUIJANO AU - BENEDETTO IELPO AU - HIPOLITO DURAN AU - EDUARDO DIAZ AU - ISABEL FABRA AU - LUIS MALAVÉ AU - VALENTINA FERRI AU - ANTONIO FERRONETTI AU - RICCARDO CARUSO Y1 - 2017/05/01 UR - http://ar.iiarjournals.org/content/37/5/2523.abstract N2 - Background/Aim: Abdominal malignancies invading inferior vena cava present high postoperative morbidity and poor prognosis that has been decreasing in the last years. Our aim was to present and discuss a series of resected tumors invading the inferior vena cava from the origin of the hepatic vein to the common iliac veins (Level I and II). Materials and Methods: We retrospectively evaluated from 2005 to 2015 short- and long-term results of 20 consecutive surgical resections of tumors with associated inferior vena cava resection at Levels I and II performed at the Sanchinarro Hospital, Madrid, Spain. Results: The series included 4 leiomyosarcomas, 3 pancreatic cancers, 2 germinal cancers, 5 renal cancers, 4 liver cancers and 2 adrenal cancers. There were 7 circular cava resections, all of them replaced by polytetrafluoroethylene (PTFE) graft and 13 primary repairs. Sapheno-femoral arterio-venous fistulas have been performed in 6 cases. Early postoperative complications occurred in 11 cases (57.9%) and mortality in one case. Graft thrombosis occurred in one case at 14 months from surgery (1/7, 14.2%). Conclusion: Surgical resection with combined inferior vena cava resection can be performed in selected patients with acceptable morbidity and mortality in light of the recent advancement in surgical technique. ER -